APA (7th ed.) Citation

R, L., ML, H., EJ, L., R, V., J, B., E, B., . . . AJ, S. (2024). Tirzepatide for Metabolic Dysfunction-Associated Steatohepatitis with Liver Fibrosis. The New England journal of medicine, 391(4), 299. https://doi.org/10.1056/NEJMoa2401943

Chicago Style (17th ed.) Citation

R, Loomba, et al. "Tirzepatide for Metabolic Dysfunction-Associated Steatohepatitis with Liver Fibrosis." The New England Journal of Medicine 391, no. 4 (2024): 299. https://doi.org/10.1056/NEJMoa2401943.

MLA (9th ed.) Citation

R, Loomba, et al. "Tirzepatide for Metabolic Dysfunction-Associated Steatohepatitis with Liver Fibrosis." The New England Journal of Medicine, vol. 391, no. 4, 2024, p. 299, https://doi.org/10.1056/NEJMoa2401943.